Evaluation of clomiphene effect in the Treatment of idiopathic premature Ejaculation

The efficacy of clomiphene in the Treatment of idiopathic premature Ejaculation: A double-blind placebo controlled study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201501071981N6

Enrollment

126

Registered

2015-02-09

Start date

2012-02-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premature ejaculation. Premature ejaculation

Interventions

Intervention 1: In intervention group oraly 50 mg clomiphene daily for 3 months. Intervention 2: in control group oraly placebo ,daily for 3 months.

Treatment - Drugs

In intervention group oraly 50 mg clomiphene daily for 3 months

in control group oraly placebo ,daily for 3 months

Eligibility

Sex/Gender

Male

Age

24 Years to 57 Years

Inclusion criteria

Inclusion criteria: Inclusion Inclusion : male ;married; idiopathic premature ejaculation exclusion criteria : single ; Known cause premature ejaculations

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Duration of ejaculation. Timepoint: after 3 months intervention. Method of measurement: with cronometer from erection to ejaculation by patients wife.	—

Secondary

Measure	Time frame
Sexuality indices. Timepoint: before and after 3 months intervention. Method of measurement: by questinaires.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Ali Asghar Ketabchi

Kerman University of Medical Sciences

dr.ketabchi@gmail.com+98 34 3211 4348

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026